Open Source Health's CEO Sonya Satveit and Patient Advisory Board Panel Discussion at PCOS Challenge Symposium in Atlanta

Press Release | Open Source Health Inc., PCOS Challenge | September 23, 2016

Toronto, Ontario, Canada / TheNewswire / September 23, 2016: Open Source Health Inc. (CSE:OSH), (Frankfurt:0OS) a cloud based precision medicine platform for women that puts control into the hands of women to educate, advocate and collaborate on their own healthcare is pleased to announce the participation of myAva’s Patient Advisory Board, along with CEO, Sonya Satveit and Medical Advisor, Dr. Fiona McCullough and in discussion panel at PCOS Challenge’s PCOS Symposium in Atlanta, Georgia.

“This is a wonderful opportunity for myAva’s Patient Advisory Board members who are participating in Precision Medicine PCOS Program to discuss the progress to-date with hundreds of women attending this symposium, “states Sonya Satveit, CEO of Open Source Health Inc., “While we are still early in the launch of the program we have seen a lot of positive results and the board members are excited to share their involvement as trailblazers to help empower other women with PCOS.”

The PCOS Challenge Symposium and Bolt for PCOS 5K Run/Walk takes place in Atlanta, GA, on September 24 and 25.  The Patient Advisory Board has formed a team called the PCOS Princesses to participate in the 5K and is participating along with myAva providers to take on this challenge.   The informative presentations from this day-long symposium will be available online at after the conference.

OSH also announces the issuance of 30,000 stock options to three of the women on the OSH PCOS Advisory Board for their expanded role in patient engagement, chair of the advisory panel and lead coordinator on the “Cost of PCOS” market survey.  Issuance date is September 19, 2016 and options are priced at $0.14, vest in one year and expire in 10 years.

About PCOS Challenge:

PCOS Challenge, Inc. is the leading 501(c)(3) nonprofit support organization advancing the cause for girls and women with Polycystic Ovary Syndrome, serving over 38,000 members. PCOS is one of the most critical, under-diagnosed, underfunded and neglected areas of health. There is a huge health disparity when it comes to PCOS diagnosis and support. 50% of women and girls with PCOS are going undiagnosed. Additionally, it often takes women several years and up to seven doctors before they can find someone who can help them with the condition. Despite affecting millions of lives and families and the serious health consequences, PCOS awareness and support organizations, receive less than 0.1% of the government, corporate, foundation, and community funding that other health conditions receive. Our vision is that PCOS is treated as a public health priority.

About Open Source Health Inc.:

OSH has developed a cloud-based precision medicine platform called myAva, which is licensed to clinics and providers to enable the delivery of precision medicine, specifically for women’s health.  By collecting and analyzing molecular-level data we will create a digital version of each patient, uncovering disease markers at an early stage allowing women and their providers to take a proactive approach to achieve optimal health. myAva sets the new standard of care for women's health.  The initial launch of myAva is focused at PCOS (Polycystic Ovary Syndrome), which affects 7 million women in the United States and 116 million women worldwide.

For more information, visit


For further information, please contact Investor Relations at Open Source Health Inc.
Toll Free: 1.866.403.1933 in North America

International Calling: +01.647.872.9986

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Open Source Health Inc. (“OSH”), including, but not limited to, the impact of general economic conditions, industry conditions and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

The forward-looking statements contained in this press release are made as of the date of this press release, and OSH does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.